CompletedNot Applicable

APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias

Germany156 participantsStarted 2000-08

Plain-language summary

The goal of APART is the assessment of the therapeutic and preventive stimulation algorithms of the Medtronic AT500 and following devices in patients with atrial tachyarrhythmias and an indication for cardiac pacing according to the German guidelines. Medication is controlled throughout the study with a beta-blocker as the only antiarrhythmic drug.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Indication for cardiac pacing according to the German guidelines * Documented (electrocardiogram; ECG) atrial arrhythmia during the last three months before enrollment * Willingness to terminate antiarrhythmic drugs until the first recurrence of an atrial arrhythmia * Sinus rhythm during 24 hours before implant of the device Exclusion Criteria: * Ejection fraction below 40% * Mechanic prosthesis of the tricuspid valve * Indication to implantable cardioverter defibrillator (ICD)-implantation * Pregnancy

What they're measuring

Incidence of symptomatic and/or persistent re-occurrences of atrial arrhythmias

Timeframe: 2 years

Time to first re-occurrence of first symptomatic or persistent atrial arrhythmia

Timeframe: 2 years

Trial details

NCT IDNCT00170274

SponsorMedtronic Cardiac Rhythm and Heart Failure

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-06

View on ClinicalTrials.gov More Tachyarrhythmia trials